Back to Trades
Flynn James E
Director10% OwnerCIK 0001352546
Total Volume
$2.3B
8 filings
Purchases
$55.0M
7 buy txns
Sales
$70.9M
2 sell txns
Net Activity
-$15.9M
net sold
Profile
- Filings
- 8
- Buy transactions
- 7
- Sell transactions
- 2
- Companies
- 3
- Active
- 2025–2026
Flynn James E, Director, 10% Owner, has filed 8 SEC reports (2025–2026), spread across 3 companies, totaling $2.3B in disclosed volume. Weighing $55.0M bought versus $70.9M sold, the history is a roughly balanced mix of buying and selling. The largest single open-market purchase on record is $30.0M in Larimar Therapeutics, Inc.. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
8 loaded
| Jul 17 | NUVL Nuvalent, Inc. | Flynn James E | Director, 10% Owner | Disposed | $2.1B |
| Jun 18 | NUVL Nuvalent, Inc. | Flynn James E | Director, 10% Owner | Grant | $0 |
| Jun 11 | PBLS Parabilis Medicines, Inc. | Flynn James E | 10% Owner | Conversion | $0 |
| Jun 9 | PBLS Parabilis Medicines, Inc. | Flynn James E | 10% Owner | Other | $0 |
| May 20 | LRMR Larimar Therapeutics, Inc. | Flynn James E | Director, 10% Owner | Award | $183.6K |
| Mar 2 | LRMR Larimar Therapeutics, Inc. | Flynn James E | Director, 10% Owner | Buy | $25.0M |
| Nov 24 | NUVL Nuvalent, Inc. | Flynn James E | Director, 10% Owner | Sell | $70.9M |
| Aug 4 | LRMR Larimar Therapeutics, Inc. | Flynn James E | Director, 10% Owner | Buy | $30.0M |
8 filings